D-cycloserine

D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.

Cross Reference

Introduction

To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with D-cycloserine?

D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with D-cycloserine

MeSH term MeSH ID Detail
Starvation D013217 47 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with D-cycloserine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with D-cycloserine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with D-cycloserine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with D-cycloserine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with D-cycloserine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with D-cycloserine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with D-cycloserine

Download all related citations
Per page 10 20 50 100 | Total 2271
Authors Title Published Journal PubMed Link
Forsyth JK et al. Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain. 2015 Proc. Natl. Acad. Sci. U.S.A. pmid:26621715
Adongo DW et al. Antidepressant-Like Effect of the Leaves of Pseudospondias microcarpa in Mice: Evidence for the Involvement of the Serotoninergic System, NMDA Receptor Complex, and Nitric Oxide Pathway. 2015 Biomed Res Int pmid:26539489
Kumagai T et al. High-Level Heterologous Production of D-Cycloserine by Escherichia coli. 2015 Appl. Environ. Microbiol. pmid:26341210
Chaturvedi SK et al. Unraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical Insight. 2015 PLoS ONE pmid:26312749
Aggarwal R et al. XDR TB presenting as a transphyseal lytic lesion in the proximal tibia. 2015 BMJ Case Rep pmid:26264953
Uda N et al. The structural and mutational analyses of O-ureido-L-serine synthase necessary for D-cycloserine biosynthesis. 2015 FEBS J. pmid:26207937
Kuznetsov NA et al. Pre-steady-state kinetic and structural analysis of interaction of methionine γ-lyase from Citrobacter freundii with inhibitors. 2015 J. Biol. Chem. pmid:25398880
Price M et al. An investigation of outcome expectancies as a predictor of treatment response for combat veterans with PTSD: comparison of clinician, self-report, and biological measures. 2015 Depress Anxiety pmid:25703611
Ortiz V et al. The effect of Midazolam and Propranolol on fear memory reconsolidation in ethanol-withdrawn rats: influence of d-cycloserine. 2015 Int. J. Neuropsychopharmacol. pmid:25617327
Krings JG et al. A novel treatment for tinnitus and tinnitus-related cognitive difficulties using computer-based cognitive training and D-cycloserine. 2015 JAMA Otolaryngol Head Neck Surg pmid:25356570
Wu IT et al. Amygdaloid zif268 participated in the D-cycloserine facilitation effect on the extinction of conditioned fear. 2015 Psychopharmacology (Berl.) pmid:26282370
Sarıdoğan GE et al. D-Cycloserine acts via increasing the GluN1 protein expressions in the frontal cortex and decreases the avoidance and risk assessment behaviors in a rat traumatic stress model. 2015 Behav. Brain Res. pmid:26225843
de Kleine RA et al. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder. 2015 J Anxiety Disord pmid:26121495
Sugiyama A et al. Systemic administration of riluzole enhances recognition memory and facilitates extinction of fear memory in rats. 2015 Neuropharmacology pmid:26116528
Andersson E et al. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial. 2015 JAMA Psychiatry pmid:25970252
Filippi A et al. Electronic structure and conformational flexibility of D-cycloserine. 2015 Phys Chem Chem Phys pmid:25966830
Ori R et al. Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. 2015 Cochrane Database Syst Rev pmid:25957940
Urbano M et al. A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders. 2015 J Neuropsychiatry Clin Neurosci pmid:25923852
Marin MF et al. Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers. 2015 Curr Psychiatry Rep pmid:25894356
Zhou H et al. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study. 2015 Clin Ther pmid:25869627
Byrne SP et al. D-cycloserine enhances generalization of fear extinction in children. 2015 Depress Anxiety pmid:25775435
Urbano M et al. A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder. 2014 May-Jun Clin Neuropharmacol pmid:24824660
Wellmann KA et al. D-Cycloserine ameliorates social alterations that result from prenatal exposure to valproic acid. 2014 Brain Res. Bull. pmid:25130667
Gazarini L et al. PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation. 2014 Int. J. Neuropsychopharmacol. pmid:25539509
Warmus BA et al. Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia. 2014 J. Neurosci. pmid:25471585
Rathnaiah G et al. Generation and screening of a comprehensive Mycobacterium avium subsp. paratuberculosis transposon mutant bank. 2014 Front Cell Infect Microbiol pmid:25360421
Belloni V and Scaraffia PY Exposure to L-cycloserine incurs survival costs and behavioral alterations in Aedes aegypti females. 2014 Parasit Vectors pmid:25129074
Khan S et al. Patch-testing for the management of hypersensitivity reactions to second-line anti-tuberculosis drugs: a case report. 2014 BMC Res Notes pmid:25128289
Combs VM et al. D-cycloserine 24 and 48 hours after asphyxial cardiac arrest has no effect on hippocampal CA1 neuropathology. 2014 J. Cereb. Blood Flow Metab. pmid:25099755
Rodrigues H et al. Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis. 2014 PLoS ONE pmid:24991926
McGuire JF et al. Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder. 2014 Expert Rev Neurother pmid:24972729
Scholl J et al. A role beyond learning for NMDA receptors in reward-based decision-making-a pharmacological study using d-cycloserine. 2014 Neuropsychopharmacology pmid:24924800
Charan M et al. Sulfur mobilization for Fe-S cluster assembly by the essential SUF pathway in the Plasmodium falciparum apicoplast and its inhibition. 2014 Antimicrob. Agents Chemother. pmid:24709262
Hofmann SG D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse. 2014 Depress Anxiety pmid:24677604
Cherry KM et al. Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke. 2014 J. Neurophysiol. pmid:24671538
Scheeringa MS and Weems CF Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress. 2014 J Child Adolesc Psychopharmacol pmid:24506079
Cain CK et al. d-Cycloserine augmentation of cognitive remediation in schizophrenia. 2014 Schizophr. Res. pmid:24485587
Bolkan SS and Lattal KM Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior. 2014 Neurobiol Learn Mem pmid:24374132
Mataix-Cols D et al. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial. 2014 Br J Psychiatry pmid:24262813
Difede J et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. 2014 Neuropsychopharmacology pmid:24217129
Chow SE et al. Resveratrol induced ER expansion and ER caspase-mediated apoptosis in human nasopharyngeal carcinoma cells. 2014 Apoptosis pmid:24264887
de Kleine RA et al. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder. 2014 J Psychiatr Res pmid:24183818
Ponnuchamy S et al. Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones. 2014 Bioorg. Med. Chem. Lett. pmid:24472146
Behera C et al. Antitubercular drug-induced violent suicide of a hospitalised patient. 2014 BMJ Case Rep pmid:24395874
Yaroshenko DV et al. Development and validation of a LC-MS/MS method for D-cycloserine determination in human plasma for bioequivalence study. 2014 Anal Bioanal Chem pmid:24337137
Lungwitz EA et al. The role of the medial prefrontal cortex in regulating social familiarity-induced anxiolysis. 2014 Neuropsychopharmacology pmid:24157502
Venir E et al. Involvement of alanine racemase in germination of Bacillus cereus spores lacking an intact exosporium. 2014 Arch. Microbiol. pmid:24346000
Huang TN et al. Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality. 2014 Nat. Neurosci. pmid:24441682
Muscia GC et al. Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents. 2014 Eur J Med Chem pmid:24412719
Mpagama SG et al. Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. 2014 Antimicrob. Agents Chemother. pmid:24247125
Ribbens JJ et al. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease. 2014 Mol. Genet. Metab. pmid:24094551
Rothbaum BO et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. 2014 Am J Psychiatry pmid:24743802
Neylan TC Pharmacologic augmentation of extinction learning during exposure therapy for PTSD. 2014 Am J Psychiatry pmid:24880503
Halouska S et al. Metabolomics analysis identifies d-Alanine-d-Alanine ligase as the primary lethal target of d-Cycloserine in mycobacteria. 2014 J. Proteome Res. pmid:24303782
Danac R and Mangalagiu II Antimycobacterial activity of nitrogen heterocycles derivatives: bipyridine derivatives. Part III. 2014 Eur J Med Chem pmid:24268596
Ahmed M et al. Structures of cycloserine and 2-oxazolidinone probed by X-ray photoelectron spectroscopy: theory and experiment. 2014 J Phys Chem A pmid:24821292
Rothbaum BO et al. Response to Smith. 2014 Am J Psychiatry pmid:25756637
Smith E Possible negative effects of extinction learning on outcomes for patients receiving exposure therapy. 2014 Am J Psychiatry pmid:25756636
Rothbaum BO and Ressler K Response to Granoff. 2014 Am J Psychiatry pmid:25756635
Granoff AL The impact of benzodiazepine management in the randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy. 2014 Am J Psychiatry pmid:25756634
Portero-Tresserra M et al. D-cycloserine prevents relational memory deficits and suppression of long-term potentiation induced by scopolamine in the hippocampus. 2014 Eur Neuropsychopharmacol pmid:25453488
Spotlights on our sister journals: ChemBioChem 11/2014. 2014 Chembiochem pmid:25045077
Fraschetti C et al. Role of the solvent on the stability of cycloserine under ESI-MS conditions. 2014 J Mass Spectrom pmid:25044845
Gomes FV et al. D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats. 2014 Behav. Brain Res. pmid:24931794
Linares IM et al. Neuroimaging correlates of pharmacological and psychological treatments for specific phobia. 2014 CNS Neurol Disord Drug Targets pmid:24923351
Hung WY et al. Serum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in Northern Taiwan. 2014 Int. J. Tuberc. Lung Dis. pmid:24903799
Donzis EJ and Thompson LT D-cycloserine enhances both intrinsic excitability of CA1 hippocampal neurons and expression of activity-regulated cytoskeletal (Arc) protein. 2014 Neurosci. Lett. pmid:24793770
Hong W et al. Molecular basis underlying Mycobacterium tuberculosis D-cycloserine resistance. Is there a role for ubiquinone and menaquinone metabolic pathways? 2014 Expert Opin. Ther. Targets pmid:24773568
Handford CE et al. The effect of the mGlu5 negative allosteric modulator MTEP and NMDA receptor partial agonist D-cycloserine on Pavlovian conditioned fear. 2014 Int. J. Neuropsychopharmacol. pmid:24674862
Kugathasan R et al. Cycloserine as an alternative urinary tract infection therapy: susceptibilities of 500 urinary pathogens to standard and alternative therapy antimicrobials. 2014 Eur. J. Clin. Microbiol. Infect. Dis. pmid:24474246
Baran H and Kepplinger B D-Cycloserine lowers kynurenic acid formation--new mechanism of action. 2014 Eur Neuropsychopharmacol pmid:24189377
Shohami E and Biegon A Novel approach to the role of NMDA receptors in traumatic brain injury. 2014 CNS Neurol Disord Drug Targets pmid:24168367
Melkonian LO et al. [Regulation of key enzymes of L-alanine biosynthesis by Brevibacterium flavum producer strains]. 2013 Mar-Apr Prikl. Biokhim. Mikrobiol. pmid:23795472
Price KL et al. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals. 2013 Psychopharmacology (Berl.) pmid:22234379
Yoon JH et al. Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers. 2013 Addict Behav pmid:22560371
Maimakov T et al. Treatment of tuberculosis in South Kazakhstan: clinical and economical aspects. 2013 Medicina (Kaunas) pmid:24375246
Smits JA et al. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables. 2013 J Consult Clin Psychol pmid:23937345
Burket JA et al. D-Cycloserine improves sociability in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders with altered Ras/Raf/ERK1/2 signaling. 2013 Brain Res. Bull. pmid:23685206
Rodebaugh TL and Lenze EJ Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy. 2013 J Clin Psychiatry pmid:23656850
Kranjac D et al. Peripheral administration of D-cycloserine rescues memory consolidation following bacterial endotoxin exposure. 2013 Behav. Brain Res. pmid:23295393
Rodebaugh TL et al. A high-throughput clinical assay for testing drug facilitation of exposure therapy. 2013 Depress Anxiety pmid:23283838
Prosser GA and de Carvalho LP Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine. 2013 FEBS J. pmid:23286234
Portero-Tresserra M et al. D-cycloserine in the basolateral amygdala prevents extinction and enhances reconsolidation of odor-reward associative learning in rats. 2013 Neurobiol Learn Mem pmid:23200640
Oda K et al. Crystallographic study to determine the substrate specificity of an L-serine-acetylating enzyme found in the D-cycloserine biosynthetic pathway. 2013 J. Bacteriol. pmid:23396912
Wei AC et al. A facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines acting as antimycobacterial agents. 2013 Bioorg. Med. Chem. Lett. pmid:23352268
Smits JA et al. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. 2013 Biol. Psychiatry pmid:23332511
Baisa G et al. Characterization of Escherichia coli D-cycloserine transport and resistant mutants. 2013 J. Bacteriol. pmid:23316042
Saito Y et al. Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation. 2013 Synapse pmid:23152167
Peters J and De Vries TJ D-cycloserine administered directly to infralimbic medial prefrontal cortex enhances extinction memory in sucrose-seeking animals. 2013 Neuroscience pmid:23159319
Heresco-Levy U et al. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression. 2013 Int. J. Neuropsychopharmacol. pmid:23174090
Villarejo-Rodríguez I et al. Learning deficits in an odor reward-task induced by parafascicular thalamic lesions are ameliorated by pretraining D-cycloserine in the prelimbic cortex. 2013 Behav. Brain Res. pmid:23124092
Tart CD et al. Augmentation of exposure therapy with post-session administration of D-cycloserine. 2013 J Psychiatr Res pmid:23098672
Hung WC et al. Association of a D-alanyl-D-alanine carboxypeptidase gene with the formation of aberrantly shaped cells during the induction of viable but nonculturable Vibrio parahaemolyticus. 2013 Appl. Environ. Microbiol. pmid:24056454
Benson AD et al. Balb/c mice treated with D-cycloserine arouse increased social interest in conspecifics. 2013 Brain Res. Bull. pmid:24157954
Smits JA et al. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. 2013 J Psychiatr Res pmid:23870811
Preuss J et al. Characterization of tryptophan aminotransferase 1 of Malassezia furfur, the key enzyme in the production of indolic compounds by M. furfur. 2013 Exp. Dermatol. pmid:24118363
Prosser GA and de Carvalho LP Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine in Mycobacterium tuberculosis. 2013 ACS Med Chem Lett pmid:24478820
Sukhanov DS et al. [Pharmacological activity of runihol and S-adenosyl-L-methionine in rats with experimental liver damage by reserve antituberculosis drugs]. 2013 Eksp Klin Farmakol pmid:24432566
Rapp A et al. Treatment of pediatric anxiety disorders. 2013 Ann. N. Y. Acad. Sci. pmid:24279893
Mantu D et al. Design, synthesis and antimycobacterial activity of some new pyridazine derivatives: bis-pyridazine. Part IV. 2013 Infect Disord Drug Targets pmid:24552228